Diabetes mellitus / triglyceride

Dodecapeptides preventing glucose and triglyceride assimilation

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

SUMMARY OF THE INVENTION Dodecapeptides of the formula: ##STR2## where X.sub.1 is either D- or L- Lys, Arg, His or Orn; X.sub.2 is either D- or L- Asn, His, Glu, Asp, Tyr or Trp; X.sub.3 is either D- or L- Trp; the linear precursor intermediates thereof and pharmaceutically acceptable salts and

Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF INVENTION The use of aldose reductase inhibitors (ARIs) for the treatment of diabetic complications is well known. The complications arise from elevated levels of glucose in tissues such as the nerve, kidney, retina and lens that enters the polyol pathway and is converted to sorbitol

Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF INVENTION The use of aldose reductase inhibitors (ARIs) for the treatment of diabetic complications is well known. The complications arise from elevated levels of glucose in tissues such as the nerve, kidney, retina and lens that enters the polyol pathway and is converted to sorbitol

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

DESCRIPTION This invention relates to the use of nucleic acid sequences of the MAP kinase-interacting kinase (Mnk) gene family and amino acid sequences encoded thereby, and to the use of these sequences or effectors of Mnk nucleic acids or polypeptides, particularly Mnk kinase inhibitors and

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to PCT Patent Application No. PCT/EP02/03540 filed Mar. 28, 2002 and European Patent Applications No. EP01 108 315.1 filed Apr. 2, 2001 and EP01 113 419.4 filed Jun. 1, 2001. DESCRIPTION This invention relates to the use of

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

DESCRIPTION This invention relates to the use of nucleic acid and amino acid sequences of protein disulfide isomerase and ABC transporter homologous proteins, and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases and disorders related to body-weight

Compositions and methods for the treatment of metabolic syndrome

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

PRIORITY The present application claims the benefit of Indian Provisional Patent Application No. 1853/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/051596 filed on 28 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into

Carboxyalkylethers, formulations, and treatment of vascular diseases

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to compounds which are dialkyl ethers having terminal carboxy or tetrazole groups. The compounds are useful for lowering certain plasma lipids in animals, including Lp(a), triglycerides, VLDL-cholesterol, and LDL-cholesterol, and elevating others such as

Carboxyalkylethers, formulations, and treatment of vascular diseases

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to compounds which are dialkyl ethers having terminal carboxy or tetrazole groups. The compounds are useful for lowering certain plasma lipids in animals, including Lp(a), triglycerides, VLDL-cholesterol, and LDL-cholesterol, and elevating others such as

Carboxyalkylethers, formulations, and treatment of vascular diseases

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF THE INVENTION Vascular diseases such as coronary heart disease, stroke, restenosis, and peripheral vascular disease, remain the leading cause of death and disability throughout the world. About 1.5 million people die each year in the US alone from myocardial infarction resulting from

Carboxyalkylethers, formulations, and treatment of vascular diseases

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to compounds which are dialkyl ethers having terminal carboxy or tetrazole groups. The compounds are useful for lowering certain plasma lipids in animals, including Lp(a), triglycerides, VLDL-cholesterol, and LDL-cholesterol, and elevating others such as

Therapeutic uses of Dunaliella powder

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to the use of crude Dunaliella bardawil powder in the treatment of a number of conditions including high triglyceride and low high-density lipoprotein (HDL) cholesterol levels, atherosclerosis and diabetes. REFERENCES The following is a list of

Therapeutic uses of Dunaliella powder

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to the use of crude Dunaliella bardawil powder in the treatment of a number of conditions including high triglyceride and low high-density lipoprotein (HDL) cholesterol levels, atherosclerosis and diabetes. REFERENCES The following is a list of

Therapeutic uses of Dunaliella powder

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

FIELD OF THE INVENTION This invention relates to the use of crude Dunaliella bardawil powder in the treatment of a number of conditions including high triglyceride and low high-density lipoprotein (HDL) cholesterol levels, atherosclerosis and diabetes. REFERENCES The following is a list of

Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor

Hanya pengguna terdaftar yang dapat menerjemahkan artikel

Masuk daftar

BACKGROUND OF INVENTION 1. Field of the Invention The present invention relates to pharmaceutical compositions, and in particular to pharmaceutical compositions containing an aldose reductase inhibitor (ARI) and an angiotensin converting enzyme (ACE) inhibitor, is useful in the prevention and

diabetes mellitus/triglyceride

Dodecapeptides preventing glucose and triglyceride assimilation

Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids

Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Compositions and methods for the treatment of metabolic syndrome

Carboxyalkylethers, formulations, and treatment of vascular diseases

Carboxyalkylethers, formulations, and treatment of vascular diseases

Carboxyalkylethers, formulations, and treatment of vascular diseases

Carboxyalkylethers, formulations, and treatment of vascular diseases

Therapeutic uses of Dunaliella powder

Therapeutic uses of Dunaliella powder

Therapeutic uses of Dunaliella powder

Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor

Database tanaman obat terlengkap yang didukung oleh sains